NCT05366634View on ClinicalTrials.gov

A Single Ascending Dose Study to Evaluate MDK-703 in Healthy Adult Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

June 30, 2022

Primary Completion Date

December 28, 2022

Study Completion Date

December 28, 2022

Conditions
Healthy Volunteers
Interventions
BIOLOGICAL

MDK-703 or Placebo

Injection

Trial Locations (1)

Unknown

Medikine Clinical Site, Herston

Sponsors

Lead Sponsor

Medikine, Inc.
All Listed Sponsors
collaborator

Medikine Australia Pty Ltd.

UNKNOWN

lead

Medikine, Inc.

INDUSTRY

NCT05366634 - A Single Ascending Dose Study to Evaluate MDK-703 in Healthy Adult Volunteers | Biotech Hunter | Biotech Hunter